2 papers1 finding
Risk stratification model
upin humans1
risk stratification model predicts squamous cell carcinoma in humans (AUC 0.90 (95% CI, 0.86-0.93)).
Humans15 years
Risk Stratification Models for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant
JAMA dermatology12 Aug 2026
Jiangsu Simcere Pharmaceutical
Company1 trialPhase 4290 people
Company1 trialPhase 4143 people
Company1 trialPhase 3500 people
Company1 trialPhase 3483 people
Company1 trialPhase 35 people
Company1 trialPhase 2153 people
Company1 trialPhase 230 people
Company1 trialPhase 1/24 people
National Cancer InstituteUS$1mNational Institute on AgingUS$55.1k
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention
National Cancer InstituteWeill Medical Coll of Cornell UnivUS$457.2k2023–2028
Modeling lung squamous cell carcinoma premalignancy and prevention
National Cancer InstituteUniversity of Colorado, DenverUS$583.4k2025–2030
Defining age-associated alterations in oral squamous cell carcinoma
National Institute on AgingBoston University Medical CampusUS$55.1k2023–2027
In a Swedish cohort, 5-ARI users had a 17% lower risk of laryngeal or hypopharyngeal squamous cell carcinoma than nonusers (adjusted hazard ratio, 0.83).In a Swedish cohort, 5-ARI users had a 17% lower risk of laryngeal or hypopharyngeal squamous cell carcinoma than nonusers (adjusted hazard ratio, 0.83).